⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 14, 2024AgingOpen Access

SHP2 mediates STAT3/STAT6 signaling pathway in TAM to inhibit proliferation and metastasis of lung adenocarcinoma

Guojing Chai Yingbo Nan Haili Zhao Qingchuan Hu

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study examines SHP2's influence on the STAT3/STAT6 pathway in tumor-associated macrophages (TAMs) and its impact on lung adenocarcinoma proliferation and metastasis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chai et al. (2024) studied this question.

synapsesocial.com/papers/68e6a284b6db6435876260ba https://doi.org/10.18632/aging.205799

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tumoral IL-10-activated SHP2 in macrophages promotes mammary carcinoma progression2024 · 1 citations
2Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs2024 · 8 citations
3Mechanistic studies of tyrosine phosphatase SHP2 in hypoxic environment to promote angiogenesis in HCC by modulating the ROS/Src pathwayOriginal Research · 2026
4Spatial interaction and functional status of CD68+SHP2+ macrophages in tumor microenvironment correlate with overall survival of NSCLC2024 · 12 citations
5SHP2 negatively regulates TGF-β signaling by destabilizing the TGF-β type I receptorOriginal Research · 2026